Systems announced that the six-month results from the randomized arm of the WRAPSODY Arteriovenous Access Efficacy trial ...

because this vascular access type has better patency rates and fewer infectious and thrombotic complications than prosthetic arteriovenous grafts (AVG). Two studies published in the American ...

At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 ...

Merit Medical Systems, Inc. announced the publication of the 6-month results from the randomized arm of the WAVE trial of arterio ...